Q: What is 5i thoughts about Avante Logixx's Q2 results? The market cap of this Company seems totally out of sync with the reality of its annual revenue base run rate and growth over $90 million which is largely predictable? Also management and director ownership position is high and growing.
Q: Peter; The federal government just announced that in September single sports betting will be allowed. Would this be beneficial to SCR in a major way? Rod
Q: Good morning, could you please rank these 10 small caps that the team has mentioned recently in terms of both opportunity (highest to lowest) and risk (Lowest to highest). I am unfamiliar with DCM but from your comments, and the extremely low PE, I am assuming they owe a few bucks? Could you shed some light on the company? Thx as always for tremendous guidance.
Q: Fengate holds a 40 million convertible debenture for score. When and at what price can they convert the debentures into stock. Anytime? Or after a certain period? And would it be converted at the price score is trading at or does Fengate get a discount on the price the score is trading at on the day they wish to convert?
Q: Could you please comment on vital health earning report and future prospects. Is it a hold / sell / or buy more? Could you also comment dynacert hold / sell / buy more)?
Q: thinking about a position in XBC just wandering your thoughts in the last two weeks GRN has really outperformed XBC do you still like XBC better and if so why and do you think this wouls be a good entry point for XBC T hanks
Q: Can you briefly describe the difference between these three companies? Their work seems to overlap but QST is struggling since the pandemic. Which one is most investible now for the next three years?